Clinical Trial Update: A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone. [Phase 4]

View source ↗

Summary

This document reports the completion of a 2-year Phase 4 clinical trial evaluating outcomes in schizophrenia patients treated with long-acting injectable risper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Risperdal Consta (risperidone long-acting injectable)

Snippet

Sponsor: Janssen, LP | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED